Overview
Status
Active
Registry date
2014-01-27
Share capital
50,000.00 PLN
Registered address
Żnińska 8, 04-925 Warszawa, Poland
Financials
Filing timeliness
No financial statement for 2019 – the filing deadline has passed.
- 2019not filed
- 201811/03/2019
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2018.
Division · Manufacture of basic pharmaceutical products and pharmaceutical preparations318 / 330
Top 96%
Voivodeship · Mazowieckie134,406 / 142,035
Top 95%
Country · Poland474,589 / 495,866
Top 96%
Results vs industry
Revenue
This companyUSD 19.17MedianUSD 919.05kAverageUSD 25.83m
Net profit
This companyUSD -73.85MedianUSD 14.92kAverageUSD 2.77m
Operating costs
This companyUSD 0.00MedianUSD 873.06kAverageUSD 21.43m
Assets
This companyUSD 11.94kMedianUSD 897.46kAverageUSD 31.52m
Industry
Authorized Representatives
Roman Iefimenko – Liquidator
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Leferino Investments Ltd | 74 | $9,994.60 | 74% |
Borys Artur Ornowskiage 32 | 20 | $2,701.24 | 20% |
Others | 6 | $810.37 | 6% |
Beneficial owners
No beneficial owners recorded for the company Ukrpharma.
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Feb 12, 2020 | Liquidation opened |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $111,469,394.21 | anpharm.pl | ||
| Tarchomińskie Zakłady Farmaceutyczne PolfaS.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| VercoS.A. | $43,577,172.02 | verco.com.pl | ||
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com | ||
| Stg25Branch (foreign co.) | – | glagolica.eu |
Change history
| Date | Event | |
|---|---|---|
| 2025-05-13 | Business resumed | |
| 2020-01-13 | Name change (Ukrpharma → Ukrpharma Spółka Z Ograniczoną Odpowiedzialnością W Likwidacji) | |
| 2016-01-18 | PKD change (Removed: 30 codes) | |
| 2016-01-01 | Business suspended | |
| 2014-01-27 | Entered in the register |
FAQ
The main business activity of Ukrpharma focuses on manufacture of pharmaceutical preparations.
The company was registered in the Polish National Court Register (KRS) on January 27, 2014.
The headquarters is located at: Żnińska 8, 04-925 Warszawa.
The share capital of the company is PLN 50,000 (approx. $13,506).
The latest available financial statement covers the period from January 1, 2018 to December 31, 2018.
The company reported a revenue of $19 in 2018.
No, in 2018 the company was not profitable, reporting a net loss of $74.
Last updated: 2026-04-06